CHINA BIOLOGIC PRODS HLDGS I's ticker is CBPO and the CUSIP is G21515104. A total of 83 filers reported holding CHINA BIOLOGIC PRODS HLDGS I in Q3 2018. The put-call ratio across all filers is 2.06 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $32,740,000 | +4.5% | 343,544 | +0.1% | 0.01% | 0.0% |
| Q1 2019 | $31,326,000 | +20.2% | 343,304 | 0.0% | 0.01% | +14.3% |
| Q4 2018 | $26,060,000 | -5.1% | 343,304 | 0.0% | 0.01% | 0.0% |
| Q3 2018 | $27,464,000 | -68.8% | 343,304 | -55.9% | 0.01% | -66.7% |
| Q2 2017 | $87,982,000 | – | 777,914 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Maso Capital Partners Ltd | 164,500 | $15,011,000 | 10.32% |
| HHLR ADVISORS, LTD. | 2,751,200 | $251,047,000 | 6.99% |
| Dalton Investments, Inc. | 113,851 | $10,389,000 | 4.54% |
| Point72 Hong Kong Ltd | 115,939 | $10,579,000 | 4.17% |
| York Capital Management Global Advisors, LLC | 991,233 | $90,450,000 | 4.05% |
| RUDMAN ERROL M | 58,000 | $5,293,000 | 3.57% |
| Greenwoods Asset Management Ltd | 479,580 | $43,762,000 | 2.69% |
| Parametrica Management Ltd | 3,663 | $334,000 | 0.71% |
| Temasek Holdings (Private) Ltd | 990,000 | $90,338,000 | 0.62% |
| Athos Capital Ltd | 8,290 | $756,000 | 0.49% |